MergerLinks Daily Review
MergerLinks
Join a community of 250,000+ M&A professionals. Expand your network and discover new business opportunities.
Welcome to MergerLinks Daily Review. Sign up here to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.
Morgan Stanley expects IPO wave, large M&A deals to hit Germany.
ADNOC expected to make formal offer for Covestro of about $15.9bn.
You can access today’s complete newsletter here.
Scroll down for more…
ANI Pharmaceuticals, Inc. , a diversified biopharmaceutical company, completed the acquisition of Alimera Sciences Ophthalmologie GmbH , a global pharmaceutical company, for $453m.
"We are pleased to have reached this agreement with ANI, which we believe recognizes the value we have created at Alimera and creates compelling value for our shareholders. ANI and Alimera share a common mission of putting patients first, and this complementary transaction creates a bigger platform to leverage our global infrastructure and outstanding team. I would like to thank Alimera employees, past and present, for always finding a way to help patients maintain better vision longer. We look forward to working with ANI to complete this transaction and help grow its presence in the ophthalmology segment," Rick Eiswirth, Alimera President and CEO.
Alimera was advised by Centerview Partners , Perella Weinberg , DLA Piper , CORE IR & PR (led by Scott Gordon ) and Longacre Square Partners (led by Dan Zacchei ). Financial advisors were advised by Ropes & Gray LLP . ANI Pharmaceuticals was advised by Guggenheim Partners , Raymond James , Hughes Hubbard & Reed LLP (led by Ken Lefkowitz ), Pérez-Llorca (led by Javier Gómez de Miguel ) and In-Site Communications, Inc. (led by Lisa Wilson ).
Greatland Gold , a company that engages in the exploration and development of natural resources, agreed to acquire Havieron and Telfer assets from Newmont Corporation , a gold mining company, for $475m. ?
"We are delighted to be combining the Havieron and Telfer projects under our single ownership, making Greatland a material producer of gold and copper. Through constructive bilateral discussions with Newmont, our joint venture partner at Havieron, we now have a compelling opportunity to create value for our shareholders. Havieron is a truly world class orebody with a defined pathway to become a low-cost long life gold-copper asset of significant scale," Shaun Day, Greatland Managing Director.
Greatland Gold is advised by 美国银行 (led by Karl Rozman ), Canaccord Genuity Group Inc. (led by Jeremy Dunlop ), SCP Resource Finance (led by Filipe Martins ), SPARK Advisory Partners (led by Andrew Emmott ), Sternship Advisers (led by Rob Hamilton ), King & Wood Mallesons , Simmons & Simmons , Fivemark (led by Michael Vaughan ) and Gracechurch Group (led by Harry Chathli ).
One Rock Capital Partners, LLC , a private equity firm, agreed to acquire Europe Snacks France , a private label manufacturer of savory snacks for the European market. Financial terms were not disclosed.?
"Over the past three decades, Europe Snacks has grown to be a leader in the private label market across its key product categories and geographies. We are excited to partner with the team, to build upon their strong heritage and to continue driving growth," Kurt Beyer, One Rock Partner.
One Rock is advised by Natixis Partners , Spayne Lindsay & Co. , Latham & Watkins , and Prosek Partners . Debt financing is provided by Barclays , 高盛 , Natixis Partners , Raiffeisen Bank International AG , Rabobank , and Santander .
Morgan Stanley expects IPO wave, large M&A deals to hit Germany.
Germany could see a wave of initial public offerings in Germany over the next two years as investors are keen to buy after a drought of transactions, Bloomberg reported.
“I expect as much as 10 large IPOs and would be disappointed to see less than five in Germany over the next 18 months,” Thomas Thurner, 摩根士丹利 co-head of equity capital markets for Europe, Middle East and Africa.
ADNOC expected to make formal offer for Covestro of about $15.9bn.
ADNOC Group ?is expected to make a formal offer to acquire 科思创 for about €14.4bn ($15.9bn) including debt, FT reported.
Having circled the German chemicals firm for more than a year, ADNOC in June won the target company over to disclose more data and have in-depth talks, based on an improved indicative bid of €11.7bn ($12.9bn) or €62 ($68) per share.
Interested to find more? Sign up here to get full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter here.